BOC Healthcare, the UK’s largest medical gases business, has been accredited by the Human Fertilisation and Embryology Authority (HFEA) for the storage of human reproductive cells (gametes) at its Cryobank facility.
This adds to BOC’s existing HTA (Human Tissue Authority) accreditation.
The demand for biological cryopreservation for fertility purposes is growing and this growth is set to continue. This is partly due to medical reasons and partly in response to the rising number of women in their 30s and 40s who want to delay starting a family and who want their eggs to be frozen and stored securely for possible use in the future. As demand for the cryopreservation of eggs increases this adds pressure on the availability of secure cryostorage facilities.
The BOC Cryobank is a high security, state-of-the-art facility which utilises ultra-low temperature, vapour phase, freezers. Flexible storage solutions are available to fertility clinics, ranging from entire freezers down to the storage of individual straws. In addition, disaster recovery insurance policies can be provided, allowing clinics to use BOC as their off site contingency storage facility.
Announcing the new licence, Mike Toole, Cryobank Business Manager for BOC Healthcare said, “Our state-of-the-art Cryobank facility provides peace of mind for our customers who require secure off site storage of irreplaceable samples. Flexibility is key to our offer; with solutions ranging from the storage of an individual patient’s samples to full disaster recovery plans.”